Simulands, a Zurich, Switzerland-based manufacturer of simulation equipment for medical training of cardiac interventions, raised €10m in funding.
SHS made the investment.
The company intends to use the funds to further accelerate the commercialization of its solutions.
Led by Andrea Guidotti, CEO, Simulands develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions. Its medical-grade, ISO-compliant simulators are offering procedure experience that provide real haptic responses, actual procedural imaging guidance, true understanding of device performance, catering to a wide range of experience and knowledge levels.
As a result, the company can count among its clientele large MedTech companies, including Abbott Laboratories (NYSE: ABT), Edwards Lifesciences (NYSE : EW), Boston Scientific (NYSE: BSX), as well as many others including Innovative up and coming startups in the field, who use the simulators for physician training and to internally train their field specialists.
FinSMEs
02/03/2023